Kirpal S. Bisht

Chemistry University of South Florida, Tampa, FL, United States 
Biochemistry, Organic Chemistry
"Kirpal Bisht"

Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bisht KS, Husain AA, Maknenko AM. (2016) Spatially Directional Resorcin[4]arene Cavitand Glycoconjugates for Organic Catalysis. Chemistry (Weinheim An Der Bergstrasse, Germany)
Parulekar S, Muppalla K, Husain A, et al. (2015) Multifold ring closing metathesis reactions in the formation of resorcin[4]arene cavitands Rsc Advances. 5: 25477-25484
Baskin R, Park SO, Keser? GM, et al. (2014) The Jak2 small molecule inhibitor, G6, reduces the tumorigenic potential of T98G glioblastoma cells in vitro and in vivo. Plos One. 9: e105568
Wu R, Al-Azemi TF, Bisht KS. (2014) Influence of a resorcin[4]arene core structure on the spatial directionality of multi-arm poly(ε-caprolactone)s Rsc Advances. 4: 16864-16870
Patel R, Apostolatos A, Carter G, et al. (2013) Protein kinase C δ (PKCδ) splice variants modulate apoptosis pathway in 3T3L1 cells during adipogenesis: identification of PKCδII inhibitor. The Journal of Biological Chemistry. 288: 26834-46
Kirabo A, Park SO, Wamsley HL, et al. (2012) The small molecule inhibitor G6 significantly reduces bone marrow fibrosis and the mutant burden in a mouse model of Jak2-mediated myelofibrosis. The American Journal of Pathology. 181: 858-65
Baskin R, Gali M, Park SO, et al. (2012) Identification of novel SAR properties of the Jak2 small molecule inhibitor G6: significance of the para-hydroxyl orientation. Bioorganic & Medicinal Chemistry Letters. 22: 1402-7
Majumder A, Magis AT, Park SO, et al. (2012) A46, a benzothiophene-derived compound, suppresses Jak2-mediated pathologic cell growth. Experimental Hematology. 40: 22-34
Kirabo A, Park SO, Majumder A, et al. (2011) The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow. Neoplasia (New York, N.Y.). 13: 1058-68
Kirabo A, Embury J, Kiss R, et al. (2011) The stilbenoid tyrosine kinase inhibitor, G6, suppresses Jak2-V617F-mediated human pathological cell growth in vitro and in vivo. The Journal of Biological Chemistry. 286: 4280-91
See more...